Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials
Shuyu Zhou, Chenqi Guo, Jingbo Zhai, Yu Zhang · 2026
Read Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials by Shuyu Zhou, Chenqi Guo, Jingbo Zhai, Yu Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194242.txt.
Description
Shuyu Zhou is first author on a 2026 systematic review and meta-analysis of a combined treatment for sunken facial acne scars. Fractional carbon dioxide laser resurfacing is a standard option, and adding recombinant human epidermal growth factor, a lab-made skin growth protein, is increasingly practiced. Whether the pairing beats laser alone needed gathering.
Searching eight databases to July twenty twenty-five, the authors included twelve randomized trials with one thousand and forty-four patients, all in China. The combination improved scar scores more than laser alone and shortened crusting time. Side effects, especially darkening of skin, were less frequent with the combination. Evidence certainty, though, ranged from very low to moderate, so larger, stronger trials are needed.
Catalog record
| CREATOR | Shuyu Zhou, Chenqi Guo, Jingbo Zhai, Yu Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |